{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:13:15Z","timestamp":1795111995493,"version":"4.10.3"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Eppley Institute in Cancer Biology Training Grant","award":["NCI T32CA009476"],"award-info":[{"award-number":["NCI T32CA009476"]}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R0I-CA182086A"],"award-info":[{"award-number":["R0I-CA182086A"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Redox Biology Pilot Project Fund","award":["NTSBRDF, Uni. of Nebraska, Lincoln"],"award-info":[{"award-number":["NTSBRDF, Uni. of Nebraska, Lincoln"]}]},{"name":"Nebraska Department of Health and Human Services Award","award":["LB506"],"award-info":[{"award-number":["LB506"]}],"id":[{"id":"https:\/\/ror.org\/03m7azy07","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A pro-oxidant enzyme, NADPH oxidase 4 (Nox4) has been reported to be a critical downstream effector of TGF\u03b2-induced myofibroblast transformation during fibrosis. While there are a small number of studies suggesting an oncogenic role of Nox4 derived from activated fibroblasts, direct evidence linking this pro-oxidant to the tumor-supporting CAF phenotype and the mechanisms involved are lacking, particularly in breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We targeted Nox4 in breast patient-derived CAFs via siRNA-mediated knockdown or administration of a pharmaceutical inhibitor (GKT137831). We also determine primary tumor growth and metastasis of implanted tumor cells using a stable Nox4-\/- syngeneic mouse model. Autophagic flux of CAFs was assessed using a tandem fluorescent-tagged ptfl-LC3 plasmid via confocal microscopy analysis and determination of the expression level of autophagy markers (beclin-1 and LC3B). Nox4 overexpressing CAFs depend on the Nrf2 (nuclear factor-erythroid factor 2-related factor 2) pathway for survival. We then determined the dependency of Nox4-overexpressing CAFs on the Nrf2-mediated adaptive stress response pathway for survival. Furthermore, we investigated the involvement of Birc5 on CAF phenotype (viability and collagen contraction activity) as well as the expression level of CAF markers, FAP and \u03b1SMA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found that deletion of stroma Nox4 and pharmaceutically targeting its activity with GKT137831 significantly inhibited orthotopic tumor growth and metastasis of implanted E0771 and 4T1 murine mammary carcinoma cell lines in mice. More importantly, we found a significant upregulation of Nox4 expression in CAFs isolated from human breast tumors versus normal mammary fibroblasts (RMFs). Our in situ RNA hybridization analysis for Nox4 transcription on a human breast tumor microarray further support a role of this pro-oxidant in the stroma of breast carcinomas. In addition, we found that Nox4 promotes autophagy in CAFs. Moreover, we found that Nox4 promoted survival of CAFs via activation of Nrf2, a master regulator of oxidative stress response. We have further shown Birc5 is involved as a downstream modulator of Nrf2-mediated pro-survival phenotype. Together these studies indicate a role of redox signaling via the Nox4-Nrf2 pathway in tumorigenesis and metastasis of breast cancer cells by promoting autophagy and survival of CAFs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-022-01548-6","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T05:05:04Z","timestamp":1657775104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Upregulation of Nox4 induces a pro-survival Nrf2 response in cancer-associated fibroblasts that promotes tumorigenesis and metastasis, in part via Birc5 induction"],"prefix":"10.1186","volume":"24","author":[{"given":"Shakeel","family":"Mir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana D.","family":"Ormsbee Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon J.","family":"Griess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghupathy","family":"Vengoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Tom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Kosmacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Oberley-Deegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Talmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimla","family":"Band","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa LT.","family":"Teoh-Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"1548_CR1","first-page":"307","volume":"38","author":"AM Moorman","year":"2012","unstructured":"Moorman AM, Vink R, Heijmans HJ, van der Palen J, Kouwenhoven EA. The prognostic value of tumour-stroma ratio in triple-negative breast cancer. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2012;38:307\u201313.","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"1548_CR2","doi-asserted-by":"crossref","unstructured":"Kramer CJH, Vangangelt KMH, van Pelt GW, Dekker TJA, Tollenaar R, Mesker WE. The prognostic value of tumour-stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review. Breast Cancer Res Treat 2018","DOI":"10.1007\/s10549-018-4987-4"},{"key":"1548_CR3","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s13277-012-0411-6","volume":"33","author":"S Ahn","year":"2012","unstructured":"Ahn S, Cho J, Sung J, Lee JE, Nam SJ, Kim KM, et al. The prognostic significance of tumor-associated stroma in invasive breast carcinoma. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2012;33:1573\u201380.","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med"},{"key":"1548_CR4","doi-asserted-by":"publisher","first-page":"107390","DOI":"10.18632\/oncotarget.22379","volume":"8","author":"BO Golden","year":"2017","unstructured":"Golden BO, Griess B, Mir S, Fitzgerald M, Kuperwasser C, Domann F, et al. Extracellular superoxide dismutase inhibits hepatocyte growth factor-mediated breast cancer-fibroblast interactions. Oncotarget. 2017;8:107390\u2013408.","journal-title":"Oncotarget"},{"key":"1548_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1124\/pr.110.002980","volume":"63","author":"F Jiang","year":"2011","unstructured":"Jiang F, Zhang Y, Dusting GJ. NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol Rev. 2011;63:218\u201342.","journal-title":"Pharmacol Rev"},{"key":"1548_CR6","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/s00018-012-1010-9","volume":"69","author":"S Altenhofer","year":"2012","unstructured":"Altenhofer S, Kleikers PW, Radermacher KA, Scheurer P, Rob Hermans JJ, Schiffers P, et al. The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell Mol Life Sci CMLS. 2012;69:2327\u201343.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"1548_CR7","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1089\/ars.2008.2333","volume":"11","author":"M Ushio-Fukai","year":"2009","unstructured":"Ushio-Fukai M. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal. 2009;11:1289\u201399.","journal-title":"Antioxid Redox Signal"},{"key":"1548_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1089\/ars.2009.3020","volume":"13","author":"L Chaiswing","year":"2010","unstructured":"Chaiswing L, Oberley TD. Extracellular\/microenvironmental redox state. Antioxid Redox Signal. 2010;13:449\u201365.","journal-title":"Antioxid Redox Signal"},{"key":"1548_CR9","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1089\/ars.2009.2594","volume":"11","author":"K Chen","year":"2009","unstructured":"Chen K, Craige SE, Keaney JF Jr. Downstream targets and intracellular compartmentalization in Nox signaling. Antioxid Redox Signal. 2009;11:2467\u201380.","journal-title":"Antioxid Redox Signal"},{"key":"1548_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4161\/cbt.10.3.12207","volume":"10","author":"KA Graham","year":"2010","unstructured":"Graham KA, Kulawiec M, Owens KM, Li X, Desouki MM, Chandra D, et al. NADPH oxidase 4 is an oncoprotein localized to mitochondria. Cancer Biol Ther. 2010;10:223\u201331.","journal-title":"Cancer Biol Ther"},{"key":"1548_CR11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.bbrc.2012.11.138","volume":"430","author":"EC Chan","year":"2013","unstructured":"Chan EC, Peshavariya HM, Liu GS, Jiang F, Lim SY, Dusting GJ. Nox4 modulates collagen production stimulated by transforming growth factor beta1 in vivo and in vitro. Biochem Biophys Res Commun. 2013;430:918\u201325.","journal-title":"Biochem Biophys Res Commun"},{"key":"1548_CR12","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1161\/01.RES.0000187457.24338.3D","volume":"97","author":"I Cucoranu","year":"2005","unstructured":"Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, et al. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res. 2005;97:900\u20137.","journal-title":"Circ Res"},{"key":"1548_CR13","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1073\/pnas.0401064101","volume":"101","author":"C Kuperwasser","year":"2004","unstructured":"Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A. 2004;101:4966\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1548_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","volume":"47","author":"TW Kensler","year":"2007","unstructured":"Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89\u2013116.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1548_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00204-011-0674-5","volume":"85","author":"L Baird","year":"2011","unstructured":"Baird L, Dinkova-Kostova AT. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol. 2011;85:241\u201372.","journal-title":"Arch Toxicol"},{"key":"1548_CR16","doi-asserted-by":"crossref","unstructured":"Rojo de la Vega M, Chapman E, Zhang DD. NRF2 and the Hallmarks of Cancer. Cancer Cell 2018;34:21-43","DOI":"10.1016\/j.ccell.2018.03.022"},{"key":"1548_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1158\/0008-5472.CAN-18-2723","volume":"79","author":"EW Cloer","year":"2019","unstructured":"Cloer EW, Goldfarb D, Schrank TP, Weissman BE, Major MB. NRF2 Activation in Cancer: From DNA to Protein. Can Res. 2019;79:889\u201398.","journal-title":"Can Res"},{"key":"1548_CR18","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/onc.2012.582","volume":"33","author":"ML Teoh-Fitzgerald","year":"2014","unstructured":"Teoh-Fitzgerald ML, Fitzgerald MP, Zhong W, Askeland RW, Domann FE. Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis. Oncogene. 2014;33:358\u201368.","journal-title":"Oncogene"},{"key":"1548_CR19","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1158\/0008-5472.CAN-09-1195","volume":"69","author":"ML Teoh","year":"2009","unstructured":"Teoh ML, Fitzgerald MP, Oberley LW, Domann FE. Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion. Cancer Res. 2009;69:6355\u201363.","journal-title":"Cancer Res"},{"key":"1548_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.freeradbiomed.2019.12.018","volume":"147","author":"B Griess","year":"2020","unstructured":"Griess B, Mir S, Datta K, Teoh-Fitzgerald M. Scavenging reactive oxygen species selectively inhibits M2 macrophage polarization and their pro-tumorigenic function in part, via Stat3 suppression. Free Radic Biol Med. 2020;147:48\u201360.","journal-title":"Free Radic Biol Med"},{"key":"1548_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.4161\/auto.23814","volume":"9","author":"L Wang","year":"2013","unstructured":"Wang L, Chen M, Yang J, Zhang Z. LC3 fluorescent puncta in autophagosomes or in protein aggregates can be distinguished by FRAP analysis in living cells. Autophagy. 2013;9:756\u201369.","journal-title":"Autophagy"},{"key":"1548_CR22","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1161\/CIRCRESAHA.109.213116","volume":"106","author":"T Ago","year":"2010","unstructured":"Ago T, Kuroda J, Pain J, Fu C, Li H, Sadoshima J. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res. 2010;106:1253\u201364.","journal-title":"Circ Res"},{"key":"1548_CR23","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/hep.25938","volume":"56","author":"T Aoyama","year":"2012","unstructured":"Aoyama T, Paik YH, Watanabe S, Laleu B, Gaggini F, Fioraso-Cartier L, et al. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatol (Baltimore, MD). 2012;56:2316\u201327.","journal-title":"Hepatol (Baltimore, MD)"},{"key":"1548_CR24","doi-asserted-by":"publisher","first-page":"22576","DOI":"10.1074\/jbc.M110.118976","volume":"285","author":"A Jain","year":"2010","unstructured":"Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, et al. p62\/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem. 2010;285:22576\u201391.","journal-title":"J Biol Chem"},{"key":"1548_CR25","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/1873-3468.12301","volume":"590","author":"K Taniguchi","year":"2016","unstructured":"Taniguchi K, Yamachika S, He F, Karin M. p62\/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer. FEBS Lett. 2016;590:2375\u201397.","journal-title":"FEBS Lett"},{"key":"1548_CR26","doi-asserted-by":"publisher","first-page":"E964","DOI":"10.1152\/ajpendo.00270.2013","volume":"305","author":"C Jamart","year":"2013","unstructured":"Jamart C, Naslain D, Gilson H, Francaux M. Higher activation of autophagy in skeletal muscle of mice during endurance exercise in the fasted state. Am J Physiol Endocrinol Metab. 2013;305:E964\u201374.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1548_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2014.11.003","volume":"78","author":"A Olayanju","year":"2015","unstructured":"Olayanju A, Copple IM, Bryan HK, Edge GT, Sison RL, Wong MW, et al. Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2. Free Radic Biol Med. 2015;78:202\u201312.","journal-title":"Free Radic Biol Med"},{"key":"1548_CR28","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/brain\/awq386","volume":"134","author":"RA Linker","year":"2011","unstructured":"Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain\u202f: J Neurol. 2011;134:678\u201392.","journal-title":"Brain : J Neurol"},{"key":"1548_CR29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nm1764","volume":"14","author":"G Finak","year":"2008","unstructured":"Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med. 2008;14:518\u201327.","journal-title":"Nat Med"},{"key":"1548_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s13046-019-1362-1","volume":"38","author":"F Li","year":"2019","unstructured":"Li F, Aljahdali I, Ling X. Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study? J Exp Clin Cancer Res. 2019;38:368.","journal-title":"J Exp Clin Cancer Res"},{"key":"1548_CR31","doi-asserted-by":"crossref","unstructured":"Policastro LL, Ibanez IL, Notcovich C, Duran HA, Podhajcer OL. The Tumor Microenvironment: Characterization, Redox Considerations, and Novel Approaches for Reactive Oxygen Species-Targeted Gene Therapy. Antioxid Redox Signal 2012","DOI":"10.1089\/ars.2011.4367"},{"key":"1548_CR32","doi-asserted-by":"crossref","unstructured":"Hanley CJ, Mellone M, Ford K, Thirdborough SM, Mellows T, Frampton SJ, et al. Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4. Journal of the National Cancer Institute 2018;110","DOI":"10.1093\/jnci\/djx121"},{"key":"1548_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/ijc.31316","volume":"143","author":"N Sampson","year":"2018","unstructured":"Sampson N, Brunner E, Weber A, Puhr M, Schafer G, Szyndralewiez C, et al. Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions. Int J Cancer J Int du cancer. 2018;143:383\u201395.","journal-title":"Int J Cancer J Int du cancer"},{"key":"1548_CR34","doi-asserted-by":"publisher","first-page":"816","DOI":"10.18632\/aging.100808","volume":"7","author":"M Peiris-Pages","year":"2015","unstructured":"Peiris-Pages M, Smith DL, Gyorffy B, Sotgia F, Lisanti MP. Proteomic identification of prognostic tumour biomarkers, using chemotherapy-induced cancer-associated fibroblasts. Aging. 2015;7:816\u201338.","journal-title":"Aging"},{"key":"1548_CR35","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1158\/0008-5472.CAN-13-2740","volume":"74","author":"M Augsten","year":"2014","unstructured":"Augsten M, Sjoberg E, Frings O, Vorrink SU, Frijhoff J, Olsson E, et al. Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties. Cancer Res. 2014;74:2999\u20133010.","journal-title":"Cancer Res"},{"key":"1548_CR36","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc.2017.53","volume":"17","author":"JMM Levy","year":"2017","unstructured":"Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17:528.","journal-title":"Nat Rev Cancer"},{"key":"1548_CR37","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/aps.2013.5","volume":"34","author":"YP Yang","year":"2013","unstructured":"Yang YP, Hu LF, Zheng HF, Mao CJ, Hu WD, Xiong KP, et al. Application and interpretation of current autophagy inhibitors and activators. Acta Pharmacol Sin. 2013;34:625\u201335.","journal-title":"Acta Pharmacol Sin"},{"key":"1548_CR38","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1158\/0008-5472.CAN-17-1077","volume":"77","author":"J New","year":"2017","unstructured":"New J, Arnold L, Ananth M, Alvi S, Thornton M, Werner L, et al. Secretory autophagy in cancer-associated fibroblasts promotes head and neck cancer progression and offers a novel therapeutic target. Cancer Res. 2017;77:6679\u201391.","journal-title":"Cancer Res"},{"key":"1548_CR39","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.bbrc.2015.07.086","volume":"464","author":"N Zhang","year":"2015","unstructured":"Zhang N, Ji N, Jiang W-M, Li Z-Y, Wang M, Wen J-M, et al. Hypoxia-induced autophagy promotes human prostate stromal cells survival and ER-stress. Biochem Biophys Res Commun. 2015;464:1107\u201312.","journal-title":"Biochem Biophys Res Commun"},{"key":"1548_CR40","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.4161\/cc.9.17.12928","volume":"9","author":"UE Martinez-Outschoorn","year":"2010","unstructured":"Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment. Cell Cycle. 2010;9:3515\u201333.","journal-title":"Cell Cycle"},{"key":"1548_CR41","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.4161\/cc.9.17.12908","volume":"9","author":"B Chiavarina","year":"2010","unstructured":"Chiavarina B, Whitaker-Menezes D, Migneco G, Martinez-Outschoorn UE, Pavlides S, Howell A, et al. HIF1-alpha functions as a tumor promoter in cancer-associated fibroblasts, and as a tumor suppressor in breast cancer cells. Cell Cycle. 2010;9:3534\u201351.","journal-title":"Cell Cycle"},{"key":"1548_CR42","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.biocel.2011.01.023","volume":"43","author":"UE Martinez-Outschoorn","year":"2011","unstructured":"Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Tanowitz HB, Sotgia F, et al. Stromal\u2013epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. Int J Biochem Cell Biol. 2011;43:1045\u201351.","journal-title":"Int J Biochem Cell Biol"},{"key":"1548_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1677\/erc.1.01312","volume":"14","author":"P Rolland","year":"2007","unstructured":"Rolland P, Madjd Z, Durrant L, Ellis IO, Layfield R, Spendlove I. The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease. Endocr Relat Cancer. 2007;14:73\u201380.","journal-title":"Endocr Relat Cancer"},{"key":"1548_CR44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/his.12002","volume":"62","author":"J Choi","year":"2013","unstructured":"Choi J, Jung W, Koo JS. Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer. Histopathology. 2013;62:275\u201386.","journal-title":"Histopathology"},{"key":"1548_CR45","first-page":"883","volume":"6","author":"RZ Luo","year":"2013","unstructured":"Luo RZ, Yuan ZY, Li M, Xi SY, Fu J, He J. Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer. Onco Targets Ther. 2013;6:883\u20138.","journal-title":"Onco Targets Ther"},{"key":"1548_CR46","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.18632\/oncotarget.1397","volume":"4","author":"F Venanzi","year":"2013","unstructured":"Venanzi F, Shifrin V, Sherman M, Gabai V, Kiselev O, Komissarov A, et al. Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector. Oncotarget. 2013;4:1829\u201335.","journal-title":"Oncotarget"},{"key":"1548_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2014.05.004","volume":"26","author":"T Valencia","year":"2014","unstructured":"Valencia T, Kim JY, Abu-Baker S, Moscat-Pardos J, Ahn CS, Reina-Campos M, et al. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. Cancer Cell. 2014;26:121\u201335.","journal-title":"Cancer Cell"},{"key":"1548_CR48","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ccell.2016.09.004","volume":"30","author":"A Duran","year":"2016","unstructured":"Duran A, Hernandez ED, Reina-Campos M, Castilla EA, Subramaniam S, Raghunandan S, et al. p62\/SQSTM1 by Binding to vitamin D receptor inhibits hepatic stellate cell activity, fibrosis, and liver cancer. Cancer Cell. 2016;30:595\u2013609.","journal-title":"Cancer Cell"},{"key":"1548_CR49","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1016\/j.celrep.2018.08.043","volume":"24","author":"S Goruppi","year":"2018","unstructured":"Goruppi S, Jo SH, Laszlo C, Clocchiatti A, Neel V, Dotto GP. Autophagy controls CSL\/RBPJkappa stability through a p62\/SQSTM1-dependent mechanism. Cell Rep. 2018;24:3108-14.e4.","journal-title":"Cell Rep"},{"issue":"5","key":"1548_CR50","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.molcel.2013.08.003","volume":"51","author":"Y Ichimura","year":"2013","unstructured":"Ichimura Y, Waguri S, Sou Y-S, Kageyama S, Hasegawa J, Ishimura R, et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol Cell. 2013;51(5):618\u201331. https:\/\/doi.org\/10.1016\/j.molcel.2013.08.003.","journal-title":"Mol Cell"},{"key":"1548_CR51","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/bcr2222","volume":"11","author":"XJ Ma","year":"2009","unstructured":"Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 2009;11:R7.","journal-title":"Breast Cancer Res"},{"key":"1548_CR52","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/cancers13040864","volume":"13","author":"JI Kang","year":"2021","unstructured":"Kang JI, Kim DH, Sung KW, Shim SM, Cha-Molstad H, Soung NK, et al. p62-induced cancer-associated fibroblast activation via the Nrf2-ATF6 pathway promotes lung tumorigenesis. Cancers. 2021;13:864.","journal-title":"Cancers"},{"key":"1548_CR53","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1080\/15548627.2019.1671643","volume":"16","author":"T-Y Lin","year":"2020","unstructured":"Lin T-Y, Chan H-H, Chen S-H, Sarvagalla S, Chen P-S, Coumar MS, et al. BIRC5\/Survivin is a novel ATG12\u2013ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy. 2020;16:1296\u2013313.","journal-title":"Autophagy"},{"key":"1548_CR54","doi-asserted-by":"publisher","first-page":"bio037374","DOI":"10.1242\/bio.037374","volume":"7","author":"NJ Humphry","year":"2018","unstructured":"Humphry NJ, Wheatley SP. Survivin inhibits excessive autophagy in cancer cells but does so independently of its interaction with LC3. Biol Open. 2018;7:bio037374.","journal-title":"Biol Open"},{"key":"1548_CR55","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm0897-917","volume":"3","author":"G Ambrosini","year":"1997","unstructured":"Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917\u201321.","journal-title":"Nat Med"},{"key":"1548_CR56","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817\u201326.","journal-title":"N Engl J Med"},{"key":"1548_CR57","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.2174\/092986712801661040","volume":"19","author":"F Rodel","year":"2012","unstructured":"Rodel F, Sprenger T, Kaina B, Liersch T, Rodel C, Fulda S, et al. Survivin as a prognostic\/predictive marker and molecular target in cancer therapy. Curr Med Chem. 2012;19:3679\u201388.","journal-title":"Curr Med Chem"},{"key":"1548_CR58","doi-asserted-by":"publisher","first-page":"10228","DOI":"10.1093\/nar\/gks827","volume":"40","author":"Y Hirotsu","year":"2012","unstructured":"Hirotsu Y, Katsuoka F, Funayama R, Nagashima T, Nishida Y, Nakayama K, et al. Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks. Nucleic Acids Res. 2012;40:10228\u201339.","journal-title":"Nucleic Acids Res"},{"key":"1548_CR59","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/toxsci\/kfq039","volume":"115","author":"S Gebel","year":"2010","unstructured":"Gebel S, Diehl S, Pype J, Friedrichs B, Weiler H, Sch\u00fcller J, et al. The Transcriptome of Nrf2\u2212\/\u2212 Mice Provides Evidence For Impaired cell cycle progression in the development of cigarette smoke-induced emphysematous changes. Toxicol Sci. 2010;115:238\u201352.","journal-title":"Toxicol Sci"},{"key":"1548_CR60","doi-asserted-by":"publisher","first-page":"e2020152118","DOI":"10.1073\/pnas.2020152118","volume":"118","author":"V Helfinger","year":"2021","unstructured":"Helfinger V, Gall FFV, Henke N, Kunze MM, Schmid T, Rezende F, et al. Genetic deletion of Nox4 enhances cancerogen-induced formation of solid tumors. Proceed Nat Acad Sci. 2021;118:e2020152118.","journal-title":"Proceed Nat Acad Sci"},{"key":"1548_CR61","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s12967-021-03182-w","volume":"19","author":"Y Bi","year":"2021","unstructured":"Bi Y, Lei X, Chai N, Linghu E. NOX4: a potential therapeutic target for pancreatic cancer and its mechanism. J Transl Med. 2021;19:515.","journal-title":"J Transl Med"},{"key":"1548_CR62","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/1751-2980.12651","volume":"19","author":"CT Tang","year":"2018","unstructured":"Tang CT, Gao YJ, Ge ZZ. NOX4, a new genetic target for anti-cancer therapy in digestive system cancer. J Dig Dis. 2018;19:578\u201385.","journal-title":"J Dig Dis"},{"key":"1548_CR63","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","volume":"80","author":"K Ford","year":"2020","unstructured":"Ford K, Hanley CJ, Mellone M, Szyndralewiez C, Heitz F, Wiesel P, et al. NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors. Can Res. 2020;80:1846\u201360.","journal-title":"Can Res"},{"key":"1548_CR64","first-page":"e21531","volume":"35","author":"X Wang","year":"2021","unstructured":"Wang X, Liu Z, Sun J, Song X, Bian M, Wang F, et al. Inhibition of NADPH oxidase 4 attenuates lymphangiogenesis and tumor metastasis in breast cancer. FASEB J Off Publi Fed Am Soc Exp Biol. 2021;35:e21531.","journal-title":"FASEB J Off Publi Fed Am Soc Exp Biol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-022-01548-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-022-01548-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-022-01548-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T16:20:41Z","timestamp":1724689241000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-022-01548-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1548"],"URL":"https:\/\/doi.org\/10.1186\/s13058-022-01548-6","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"assertion":[{"value":"18 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The citation for the second author, Briana D. Ormsbee Golden was incorrect.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal protocol was approved by the Institutional Animal Care and Use Committee of the University of Nebraska Medical Center and all procedures were performed in compliant with National Institutes of Health guidelines and policy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that no competing interests exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}